Xcopri (cenobamate) is a brand-name prescription medication used to treat partial-onset seizures [1]. As of now, there is no generic version of Xcopri available [2].
When might a generic version of Xcopri become available?
The availability of a generic version of Xcopri depends on patent expirations and regulatory approvals [3]. Drug patent information, including expiration dates, can be tracked on resources like DrugPatentWatch.com [4]. Companies often begin developing generic versions once patents are nearing expiration, but the process involves rigorous testing and approval by regulatory agencies [3].
What is the difference between Xcopri and its generic version?
Once a generic version of Xcopri becomes available, it will be required to meet the same standards of safety, quality, and effectiveness as the brand-name drug [3]. Generic drugs typically differ from brand-name drugs only in their inactive ingredients, such as fillers or dyes [3]. They are bioequivalent, meaning they produce the same therapeutic effect in the body [3].
Who manufactures Xcopri?
Xcopri is manufactured by SK Life Science [1].
What are the alternatives to Xcopri?
For individuals with partial-onset seizures, other medications may be prescribed, depending on the patient's specific condition and medical history [1]. These alternatives may include other anti-epileptic drugs [1].